Iron uptake and virulence in Histoplasma capsulatum

Current Opinion in Microbiology

Volumn 16, Issue 6, 2013, Pages 700-707

  Newman, Simon L ^a   Smulian, A George ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; FERRIC ION; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; HEPCIDIN; HYDROXAMIC ACID; IRON; NITRIC OXIDE SYNTHASE; SIDEROPHORE;

CELL SURVIVAL; FUNGAL VIRULENCE; FUNGICIDAL ACTIVITY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HOMEOSTASIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IRON RESTRICTION; IRON TRANSPORT; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PH; PHAGOCYTOSIS; PHAGOSOME; REVIEW;

AJELLOMYCES CAPSULATUS; FUNGI; MAMMALIA;

HISTOPLASMA; IRON; MACROPHAGES; PHAGOSOMES; VIRULENCE;

EID: 84888129825     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.09.001     Document Type: Review

References (75)

1. Ajello L. Distribution of Histoplasma capsulatum in the United States. Histoplasmosis 1971, 103-122. CC Thomas, Springfield. L. Ajello, E.W. Chick, M.F. Furcolow (Eds.).
2. Deepe G.S., Bullock W.E. Histoplasmosis: a granulomatous inflammatory response. Inflammation: Basic Principles and Clinical Correlates 1992, 943-958. Raven Press, New York. J.I. Gallin, I.M. Goldstein, R. Snyderman (Eds.).
3. Wood K.L., Hage C.A., Knox K.S., Kleiman M.B., Sannuti A., Day R.B., Wheat L.J., Twigg H.L. Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. Am J Respir Crit Care Med 2003, 167:1279-1282.
4. Newman S.L. Cell-mediated immunity to Histoplasma capsulatum. Semin Respir Infect 2001, 16:102-108.
5. Maresca B., Kobayashi G.S. Dimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi. Microbiol Rev 1989, 53:186-209.
6. Newman S.L., Lemen W., Smulian A.G. Dendritic cells restrict the transformation of Histoplasma capsulatum conidia into yeasts. Med Mycol 2011, 49:356-364.
7. Baughman R.P., Kim C.K., Vinegar A., Hendricks D.E., Schmidt D.J., Bullock W.E. The pathogenesis of experimental pulmonary histoplasmosis, Correlative studies of histopathology, bronchoalveolar lavage, and respiratory function. Am Rev Respir Dis 1986, 134:771-776.
8. Newman S.L., Bucher C., Rhodes J., Bullock W.E. Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages, Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest 1990, 85:223-230.
9. Newman S.L., Gootee L., Bucher C., Bullock W.E. Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages. Infect Immun 1991, 59:737-741.
10. Deepe G.S., Seder R.A. Molecular and cellular determinants of immunity to Histoplasma capsulatum. Res Immunol 1998, 149:397-406. (discussion 309-310).
11. Howard D.H. Intracellular behavior of Histoplasma capsulatum. J Bacteriol 1964, 87:33-38.
12. Newman S.L., Gootee L., Morris R., Bullock W.E. Digestion of Histoplasma capsulatum yeasts by human macrophages. J Immunol 1992, 149:574-580. [published erratum appears in J Immunol 1992, 149:3127].
13. Eissenberg L.G., Goldman W.E., Schlesinger P.H. Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med 1993, 177:1605-1611.
14. Bullock W.E., Wright S.D. Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J Exp Med 1987, 165:195-210.
15. Newman S.L., Gootee L., Gabay J.E. Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J Clin Invest 1993, 92:624-631.
16. Youseff B.H., Holbrook E.D., Smolnycki K.A., Rappleye C.A. Extracellular superoxide dismutase protects Histoplasma yeast cells from host-derived oxidative stress. PLoS Pathog 2012, 8:e1002713.
17. Newman S.L., Gootee L., Hilty J., Morris R.E. Human macrophages do not require phagosome acidification to mediate fungistatic/fungicidal activity against Histoplasma capsulatum. J Immunol 2006, 176:1806-1813.
18. Eissenberg L.G., Schlesinger P.H., Goldman W.E. Phagosome-lysosome fusion in P388D1 macrophages infected with Histoplasma capsulatum. J Leukoc Biol 1988, 43:483-491.
19. Taylor M.L., Espinosa-Schoelly M.E., Iturbe R., Rico B., Casasola J., Goodsaid F. Evaluation of phagolysosome fusion in acridine orange stained macrophages infected with Histoplasma capsulatum. Clin Exp Immunol 1989, 75:466-470.
20. Miethke M., Marahiel M.A. Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 2007, 71:413-451.
21. Howard D.H., Rafie R., Tiwari A., Faull K.F. The hydroxamate siderophores of Histoplasma capsulatum. Infect Immun 2000, 68:2338-2343.
22. Timmerman M.M., Woods J.P. Potential role for extracellular glutathione-dependent ferric reductase in utilization of environmental and host ferric compounds by Histoplasma capsulatum. Infect Immun 2001, 69:7671-7678.
23. Hwang L.H., Mayfield J.A., Rine J., Sil A. Histoplasma requires SID1, a member of an iron-regulated siderophore gene cluster, for host colonization. PLoS Pathog 2008, 4:e1000044.
24. Hilty J., George Smulian A., Newman S.L. Histoplasma capsulatum utilizes siderophores for intracellular iron acquisition in macrophages. Med Mycol 2011, 49:633-642.
25. Timmerman M.M., Woods J.P. Ferric reduction is a potential iron acquisition mechanism for Histoplasma capsulatum. Infect Immun 1999, 67:6403-6408.
26. Lestas A.N. The effect of pH upon human transferrin: selective labelling of the two iron-binding sites. Br J Haematol 1976, 32:341-350.
27. Gruenheid S., Canonne-Hergaux F., Gauthier S., Hackam D.J., Grinstein S., Gros P. The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J Exp Med 1999, 189:831-841.
28. Hentze M.W., Muckenthaler M.U., Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 2004, 117:285-297.
29. Newman S.L., Gootee L., Stroobant V., van der Goot H., Boelaert J.R. Inhibition of growth of Histoplasma capsulatum yeast cells in human macrophages by the iron chelator VUF 8514 and comparison of VUF 8514 with deferoxamine. Antimicrob Agents Chemother 1995, 39:1824-1829.
30. Princiotto J.V., Zapolski E.J. Difference between the two iron-binding sites of transferrin. Nature 1975, 255:87-88.
31. Krogstad D.J., Schlesinger P.H. Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. N Engl J Med 1987, 317:542-549.
32. Newman S.L., Gootee L., Brunner G., Deepe G.S. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J Clin Invest 1994, 93:1422-1429.
33. Bates G.W., Wernicke J. The kinetics and mechanism of iron (III) exchange between chelates and transferrin. J Biol Chem 1971, 246:3679-3686.
34. Wu-Hsieh B.A., Howard D.H. Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect Immun 1987, 55:1014-1016.
35. Lane T.E., Wu-Hsieh B.A., Howard D.H. Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect Immun 1993, 61:1468-1473.
36. Lane T.E., Wu-Hsieh B.A., Howard D.H. Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect Immun 1991, 59:2274-2278.
37. Lane T.E., Otero G.C., Wu-Hsieh B.A., Howard D.H. Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity. Infect Immun 1994, 62:1478-1479.
38. Lane T.E., Wu-Hsieh B.A., Howard D.H. Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates. Infect Immun 1994, 62:1940-1945.
39. Zhou P., Miller G., Seder R.A. Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-alpha plays a critical role in maintaining secondary immunity in the absence of IFN-gamma. J Immunol 1998, 160:1359-1368.
40. Fleischmann J., Wu-Hsieh B., Howard D.H. The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-gamma. J Infect Dis 1990, 161:143-145.
41. Newman S.L., Gootee L. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect Immun 1992, 60:4593-4597.
42. Nogueira N., Chaplan S., Reesink M., Tydings J., Cohn Z.A. Trypanosoma cruzi: induction of microbicidal activity in human mononuclear phagocytes. J Immunol 1982, 128:2142-2146.
43. Murray H.W., Cartelli D.M. Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. J Clin Invest 1983, 72:32-44.
44. Murray H.W., Rubin B.Y., Carriero S.M.A., Harris M., Jaffee E.A. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol 1985, 134:1982-1988.
45. Rothermel C.D., Rubin B.Y.E., Jaffe A., Murray H.W. Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-gamma-activated macrophages. J Immunol 1986, 137:689-692.
46. Newman S.L., Gootee L., Kidd C., Ciraolo G.M., Morris R. Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type 1 collagen matrices. J Immunol 1997, 158:1779-1786.
47. Byrd T.F., Horwitz M.A. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J Clin Invest 1989, 83:1457-1465.
48. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102:783-788.
49. Knutson M.D., Oukka M., Koss L.M., Aydemir F., Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A 2005, 102:1324-1328.
50. Zarnowski R., Cooper K.G., Brunold L.S., Calaycay J., Woods J.P. Histoplasma capsulatum secreted gamma-glutamyltransferase reduces iron by generating an efficient ferric reductant. Mol Microbiol 2008, 70:352-368.
51. Foster L.A. Utilization and cell-surface binding of hemin by Histoplasma capsulatum. Can J Microbiol 2002, 48:437-442.
52. Askwith C., Eide D., Van Ho A., Bernard P.S., Li L., Davis-Kaplan S., Sipe D.M., Kaplan J. The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell 1994, 76:403-410.
53. Stearman R., Yuan D.S., Yamaguchi-Iwai Y., Klausner R.D., Dancis A. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science 1996, 271:1552-1557.
54. Ramanan N., Wang Y. A high-affinity iron permease essential for Candida albicans virulence. Science 2000, 288:1062-1064.
55. Sebghati T.S., Engle J.T., Goldman W.E. Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence. Science 2000, 290:1368-1372.
56. Sullivan T.D., Rooney P.J., Klein B.S. Agrobacterium tumefaciens integrates transfer DNA into single chromosomal sites of dimorphic fungi and yields homokaryotic progeny from multinucleate yeast. Eukaryot Cell 2002, 1:895-905.
57. Marion C.L., Rappleye C.A.J., Engle T., Goldman W.E. An alpha-(1,4)-amylase is essential for alpha-(1,3)-glucan production and virulence in Histoplasma capsulatum. Mol Microbiol 2006, 62:970-983.
58. Hilty J., Smulian A.G., Newman S.L. The Histoplasma capsulatum vacuolar ATPase is required for iron homeostasis, intracellular replication in macrophages and virulence in a murine model of histoplasmosis. Mol Microbiol 2008, 70:127-139.
59. Mellman I., Fuchs R., Helenius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 1986, 55:663-700.
60. Stevens T.H., Forgac M. Structure, function and regulation of the vacuolar (H+)-ATPase. Annu Rev Cell Dev Biol 1997, 13:779-808.
61. Nishi T., Forgac M. The vacuolar (H+)-ATPases-nature's most versatile proton pumps. Nat Rev Mol Cell Biol 2002, 3:94-103.
62. Klionsky D.J., Herman P.K., Emr S.D. The fungal vacuole: composition, function, and biogenesis. Microbiol Rev 1990, 54:266-292.
63. Nelson H., Nelson N. Disruption of genes encoding subunits of yeast vacuolar H(+)-ATPase causes conditional lethality. Proc Natl Acad Sci U S A 1990, 87:3503-3507.
64. Bowman E.J., Kendle R., Bowman B.J. Disruption of vma-1, the gene encoding the catalytic subunit of the vacuolar H(+)-ATPase, causes severe morphological changes in Neurospora crassa. J Biol Chem 2000, 275:167-176.
65. Poltermann S., Nguyen M., Gunther J., Wendland J., Hartl A., Kunkel W.P., Zipfel F., Eck R. The putative vacuolar ATPase subunit Vma7p of Candida albicans is involved in vacuole acidification, hyphal development and virulence. Microbiology 2005, 151:1645-1655.
66. Iwaki T., Goa T., Tanaka N., Takegawa K. Characterization of Schizosaccharomyces pombe mutants defective in vacuolar acidification and protein sorting. Mol Genet Genomics 2004, 271:197-207.
67. Melin P., Schnurer J., Wagner E.G. Disruption of the gene encoding the V-ATPase subunit A results in inhibition of normal growth and abolished sporulation in Aspergillus nidulans. Microbiology 2004, 150:743-748.
68. Enyenihi A.H., Saunders W.S. Large-scale functional genomic analysis of sporulation and meiosis in Saccharomyces cerevisiae. Genetics 2003, 163:47-54.
69. Davis-Kaplan S.R., Compton M.A., Flannery A.R., Ward D.M., Kaplan J.T., Stevens H., Graham L.A. PKR1 encodes an assembly factor for the yeast V-type ATPase. J Biol Chem 2006, 281:32025-32035.
70. Bowman E.J., Siebers A., Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 1988, 85:7972-7976.
71. Thorpe G.W., Fong C.S., Alic N.V., Higgins J., Dawes I.W. Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes. Proc Natl Acad Sci U S A 2004, 101:6564-6569.
72. Milgrom E., Diab H., Middleton F., Kane P.M. Loss of vacuolar proton-translocating ATPase activity in yeast results in chronic oxidative stress. J Biol Chem 2007, 282:7125-7136.
73. Chao L.Y., Marletta M.A., Rine J. Sre1 an iron-modulated GATA DNA-binding protein of iron-uptake genes in the fungal pathogen Histoplasma capsulatum. Biochemistry 2008, 47:7274-7283.
74. Hwang L.H., Seth E., Gilmore S.A., Sil A. SRE1 regulates iron-dependent and -independent pathways in the fungal pathogen Histoplasma capsulatum. Eukaryot Cell 2012, 11:16-25.
75. Smulian A.G., Gibbons R.S., Demland J.A., Spaulding D.T., Deepe G.S. Expression of hygromycin phosphotransferase alters virulence of Histoplasma capsulatum. Eukaryot Cell 2007, 6:2066-2071.